0

    530313

    KIMIABL

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    KIMIA BIOSCIENCES LIMITED Share Price Today

    Investment Returns

    Over 1 Month -0.50% Over 3 Months -10.22% Over 6 Months 5.01% Over 1 Year -45.93%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    KIMIA BIOSCIENCES LIMITED fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 149.90
    • P/E Ratio (TTM) 20.13
    • Beta 1.20
    • Book Value / share 3.74
    • Return on equity 172.53%
    • EPS (TTM) 1.57
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.37
    info icon alternate text

    KIMIA BIOSCIENCES LIMITED Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 27.20
    Operating Expense 26.44
    Net Profit 0.37
    Net Profit Margin (%) 1.36
    Earnings Per Share (EPS) 0.15
    EBITDA 3.67
    Effective Tax Rate (%) 78.97
    Particulars DEC 2025 (Values in Cr)
    Revenue 30.10
    Operating Expense 25.15
    Net Profit 5.44
    Net Profit Margin (%) 18.07
    Earnings Per Share (EPS) 1.15
    EBITDA 6.64
    Effective Tax Rate (%) -7.72
    Particulars SEP 2025 (Values in Cr)
    Revenue 34.00
    Operating Expense 32.72
    Net Profit 1.02
    Net Profit Margin (%) 3.00
    Earnings Per Share (EPS) 0.21
    EBITDA 2.19
    Effective Tax Rate (%) -7.36
    Particulars JUN 2025 (Values in Cr)
    Revenue 23.58
    Operating Expense 23.74
    Net Profit 0.60
    Net Profit Margin (%) 2.54
    Earnings Per Share (EPS) 0.13
    EBITDA 3.38
    Effective Tax Rate (%) 13.04
    Particulars MAR 2025 (Values in Cr)
    Revenue 38.24
    Operating Expense 32.34
    Net Profit 1.99
    Net Profit Margin (%) 5.20
    Earnings Per Share (EPS) 0.42
    EBITDA 8.62
    Effective Tax Rate (%) 68.61
    Particulars MAR 2026 (Values in Cr)
    Revenue 114.88
    Operating Expense 108.05
    Net Profit 7.43
    Net Profit Margin (%) 6.46
    Earnings Per Share (EPS) 1.64
    EBITDA 15.89
    Effective Tax Rate (%) 12.17
    Particulars MAR 2025 (Values in Cr)
    Revenue 118.92
    Operating Expense 106.61
    Net Profit 9.61
    Net Profit Margin (%) 8.08
    Earnings Per Share (EPS) 2.03
    EBITDA 21.57
    Effective Tax Rate (%) 29.49
    Particulars MAR 2024 (Values in Cr)
    Revenue 104.88
    Operating Expense 113.70
    Net Profit -5.31
    Net Profit Margin (%) -5.06
    Earnings Per Share (EPS) -1.12
    EBITDA 1.16
    Effective Tax Rate (%) 26.18
    Particulars MAR 2023 (Values in Cr)
    Revenue 128.52
    Operating Expense 141.07
    Net Profit -9.35
    Net Profit Margin (%) -7.27
    Earnings Per Share (EPS) -1.98
    EBITDA -4.81
    Effective Tax Rate (%) 24.53
    Particulars MAR 2022 (Values in Cr)
    Revenue 124.90
    Operating Expense 130.85
    Net Profit -3.70
    Net Profit Margin (%) -2.96
    Earnings Per Share (EPS) -0.78
    EBITDA 1.56
    Effective Tax Rate (%) 26.29
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 2.11
    ROE % 172.53
    ROCE % 34.57
    Total Debt to Total Equity 7.46
    EBITDA Margin 18.14
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 0.07
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 16.69
    EBITDA Margin 1.11
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 1.15
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 4.60
    EBITDA Margin -3.74
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 3.15
    ROE % -22.20
    ROCE % -2.03
    Total Debt to Total Equity 2.57
    EBITDA Margin 1.25
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 3.90
    ROE % 32.16
    ROCE % 13.88
    Total Debt to Total Equity 2.48
    EBITDA Margin 8.17
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.68
    Total Assets 111.21
    Total Liabilities 111.21
    Total Equity 9.96
    Share Outstanding 4
    Price to Book Ratio 20.15
    Return on Assets (%) 8.64
    Return on Capital (%) 22.6
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.53
    Total Assets 99.96
    Total Liabilities 99.96
    Total Equity 0.33
    Share Outstanding 4
    Price to Book Ratio 796.14
    Return on Assets (%) -5.31
    Return on Capital (%) -12.14
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.49
    Total Assets 121.31
    Total Liabilities 121.31
    Total Equity 5.46
    Share Outstanding 4
    Price to Book Ratio 28.26
    Return on Assets (%) -7.70
    Return on Capital (%) -16.02
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.51
    Total Assets 109.49
    Total Liabilities 109.49
    Total Equity 14.88
    Share Outstanding 4
    Price to Book Ratio 11.94
    Return on Assets (%) -3.38
    Return on Capital (%) -6.67
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.67
    Total Assets 106.66
    Total Liabilities 106.66
    Total Equity 18.43
    Share Outstanding 4
    Price to Book Ratio 9.73
    Return on Assets (%) 4.78
    Return on Capital (%) 8.06
    Particulars MAR 2025 (Values in Cr)
    Net Income 13.63
    Cash from Operations 21.26
    Cash from Investing -4.70
    Cash from Financing -16.55
    Net change in Cash 0.05
    Free Cash Flow 25.86
    Particulars MAR 2024 (Values in Cr)
    Net Income -7.18
    Cash from Operations 14.50
    Cash from Investing -1.49
    Cash from Financing -13.07
    Net change in Cash -0.03
    Free Cash Flow 16.01
    Particulars MAR 2023 (Values in Cr)
    Net Income -12.38
    Cash from Operations -6.78
    Cash from Investing -2.79
    Cash from Financing 9.54
    Net change in Cash -0.02
    Free Cash Flow -3.97
    Particulars MAR 2022 (Values in Cr)
    Net Income -5.01
    Cash from Operations 8.06
    Cash from Investing -0.71
    Cash from Financing -7.66
    Net change in Cash -0.38
    Free Cash Flow 11.64
    Particulars MAR 2021 (Values in Cr)
    Net Income 5.53
    Cash from Operations 5.92
    Cash from Investing -13.60
    Cash from Financing 7.99
    Net change in Cash 0.35
    Free Cash Flow 19.48
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 34.87 14.47 1.68 267.22 23.12 38.85
    BLISS GVS PHARMA LTD. 467.40 37.63 4.16 4965.84 118.35 552.90
    CIPLA LTD 1472.95 33.25 3.45 118991.58 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 501.25 23.44 3.62 1475.23 256.40 507.20
    GLAXOSMITHKLINE PHARMACEUTICAL 2653.45 46.72 19.82 44951.04 2088.00 3202.80
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 34.87 24.38 4.49 267.22 23.12 38.85
    AMRUTAJAN HEALTH LTD 515.00 23.08 4.02 1488.90 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8103.65 105.90 23.21 20259.13 7630.00 9850.00
    BLISS GVS PHARMA LTD. 467.40 50.58 4.29 4965.84 118.35 552.90

    KIMIA BIOSCIENCES LIMITED shareholding pattern

    Holding
    24.67%
    74.93%
    0.38%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    KIMIA BIOSCIENCES LIMITED Technicals Summary

    31.68 0.22 redarrow
    red-green-graph indicator
    14 Bearish
    2 Bullish
    • 5 Days 31.60
    • 26 Days 32.30
    • 10 Days 31.90
    • 50 Days 32.70
    • 12 Days 32.00
    • 100 Days 33.20
    • 20 Days 32.20
    • 200 Days 34.70
    31.25 PIVOT
    First Support 30.56 First Resistance 32.29 Second Support 29.52 Second Resistance 32.98 Third Support 28.83 Third Resistance 34.02
    RSI 45.10 ADX 14.27 MACD -0.34 Williams % R -70.56 Commodity Channel Index (CCI) -79.91
    Date 2026-07-31 Week 4648.00 Same Day 4373.00 Month 2674.00
    1 Year 1.21 3 Year 0.95
    Over 1 Month
    -0.50% down
    Over 1 Year
    -45.93% down
    Over 3 Months
    -10.22% down
    Over 3 Years
    -3.80% down
    Over 6 Months
    5.01% down
    Over 5 Years
    -7.74% down

    KIMIA BIOSCIENCES LIMITED Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Kimia Biosciences Ltd?

    Answer Field

    Kimia Biosciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 31.68 as on Aug 03 2026 02:11 PM.

    What is the Market Cap of Kimia Biosciences Ltd Share?

    Answer Field

    The market cap of Kimia Biosciences Ltd for NSE ₹ 0.00 & for BSE ₹ 149.90 as on Aug 03 2026 02:11 PM.

    What is the 52 Week High and Low of Kimia Biosciences Ltd?

    Answer Field

    The 52 Week High and Low of Kimia Biosciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 61.99 and ₹ 23.20.

    What is 1 year return for Kimia Biosciences Ltd?

    Answer Field

    The 1 year returns on the stock has been -45.93%.

    What is the P/E Ratio of Kimia Biosciences Ltd Share?

    Answer Field

    As on Aug 03 2026 02:11 PM the price-to-earnings (PE) ratio for Kimia Biosciences Ltd share is 20.13.

    What is the PB ratio of Kimia Biosciences Ltd Share?

    Answer Field

    As on Aug 03 2026 02:11 PM, the price-to-book (PB) ratio for Kimia Biosciences Ltd share is 3.74.

    How to Buy Kimia Biosciences Ltd Share?

    Answer Field

    You can trade in Kimia Biosciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Kimia Biosciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Kimia Biosciences Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Kimia Biosciences Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |